SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NTII - Miscellaneous
An SI Board Since August 2001
Posts SubjectMarks Bans Symbol
1296 22 0 NTII
Emcee:  John McCarthy Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
11212005 - Jan 13th CTIC yahoo post ........ the * and bold are mine CTIC's John McCarthy-1/15/2005
11202005 - Jan 14th LGND In our view, that discount reflects the expectation, as weJohn McCarthy-1/15/2005
11192005 - Jan 12th MYGN Flurizan is currently being studied in a Phase 2 clinical John McCarthy-1/15/2005
11182004 - Dec 28th AXYX Axonyx Completes Phenserine Trial Tuesday December 28, 10John McCarthy-1/15/2005
1117Lottery Tickets - Short Term The stuff below is subject to errors/misspellings John McCarthy-1/14/2005
11162004 - Novel Treatments in the Pipeline for Neuropathic Pain November 19, 2004John McCarthy-1/14/2005
11152005 - Alzheimer's Patients Dosed in Memory Pharmaceuticals' Safety &John McCarthy-1/13/2005
1114aagpmeeting.orgJohn McCarthy-1/12/2005
11132004 - AD by State alz.org 2004 - AD by European country alzheimer-europe.orJohn McCarthy-1/12/2005
11122005 - Myriad Genetics Initiates Phase 3 Clinical Trial of Flurizan(TM) in AlzheJohn McCarthy-1/12/2005
11112005 - NMDA glutamate but not dopamine antagonists blocks drug-induced reinstateJohn McCarthy-1/12/2005
11102004 - Various Ancrod Links ..... ======================================= AncroJohn McCarthy-1/11/2005
11092005 - [DN] Lyrica Relieves Diabetes Pain Sat Jan 8 08:10:08 2005 Lyrica ReliJohn McCarthy-1/10/2005
1108Am J Clin Nutr. 2004 Dec;80(6):1478-86. Neuromedin beta: a strong candidate gescaram(o)uche-1/8/2005
11072004 - Schizophrenia and Glutamate abstracts 1: Proc Natl Acad Sci U S A. 2004 John McCarthy-1/7/2005
11062005 - Summary of Ongoing Memantine Trials <b>Purpose: Create central poiJohn McCarthy-1/7/2005
11052004 - neuroinvestment NEUROBIOLOGICAL TECHNOLOGIES From September 2004 Issue:John McCarthy-1/7/2005
11042005 - The Emperor Has No Clothes: Dementia Treatment on the Eve of the Aging ErJohn McCarthy-1/7/2005
11032005 - Alzheimer's Services of the Crescent City Monday, January 24, 2005 John McCarthy-1/6/2005
11022005 - Namenda / Reminyl combo trial for Moderate to Severe .. University of MeJohn McCarthy-1/6/2005
11012004 - Paul Mathews, MD. Geriatric Psychiatrist specialized in treating AlzheimeJohn McCarthy-1/6/2005
11002005 - Ruxton: Drugs Discovered That May Slow Progression of Lou Gehrig's DiJohn McCarthy-1/6/2005
10992004 - Abstracts From Professional Poster Presentations at AMCP’s 2004 EducationJohn McCarthy-1/5/2005
10982005 - New Trial Memantine and MRI Assessment Summary: Functional MRI AssessmeJohn McCarthy-1/5/2005
10972005 - Trial in the UK Nervous System Diseases: Alzheimer's disease PartJohn McCarthy-1/5/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News